Jim Causey

What does ChatGPT find for me?

There are several people named Jim/James Causey online, but one stands out strongly as a biomedical engineer and diabetes-device innovator—likely the individual you’re asking about.

Overview

James Causey is a biomedical engineer with more than 30 years in diabetes technology, insulin pumps, continuous glucose monitoring (CGM), and automated insulin delivery (AID) systems. Public profiles describe him as a former R&D leader at MiniMed/Medtronic, consultant to multiple diabetes-device companies, CEO of Simimed, and a prolific inventor.  

Career Highlights

• Led development of several landmark MiniMed insulin pumps, including the 507C, 508, and Paradigm 511 systems during MiniMed’s growth years before its acquisition by Medtronic.  
• Held senior R&D and innovation roles with companies including MiniMed, Medtronic, Insulet, Bigfoot Biomedical, and Optiscan Biomedical.  
• CEO of  Simimed, Inc.⁠, a consulting and development company focused on diabetes technologies.  

Patents and Inventions

A large number of patents and patent applications are associated with James Causey, covering:

• Insulin pumps
• Automated insulin delivery systems
• Closed-loop (“artificial pancreas”) technologies
• Wireless pump control
• CGM integration
• Drug-delivery mechanisms
• Medical device communications and cloud connectivity

Patent databases show numerous granted patents and published applications with Causey as inventor or co-inventor.  

Publications and Thought Leadership

James Causey maintains a diabetes-industry newsletter called:

Jim Causey’s Diabetes Devices Notebook⁠

The publication discusses diabetes technology, CGMs, insulin pumps, automated insulin delivery systems, regulatory developments, and industry trends.  

Academic Impact

A public Google Scholar profile for James Causey lists him as CEO of Simimed and shows substantial citation activity related to diabetes management, glucose sensing, and wearable medical devices.  

Historical Contributions

Public posts and patent records indicate involvement in several early innovations that became commonplace in modern diabetes therapy, including:

• Wireless remote control of insulin pumps
• User-assistance and decision-support systems for insulin therapy
• Integrated pump/CGM architectures
• Early concepts that evolved into modern hybrid closed-loop systems  

Reputation in the Industry

Within the diabetes-device sector, James Causey is generally known as a long-time insulin-pump and CGM developer who participated in multiple generations of diabetes technology from the early MiniMed era through current automated insulin delivery systems.  

If you’d like, I can also compile a chronological career timeline, a patent count analysis, or a history of his role in the development of MiniMed insulin pumps.